Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation
Conditions
- Diabetes Mellitus, Type I
Interventions
- DRUG: Low Molecular Weight Sulfated Dextran (LMW-SD)
- DRUG: Heparin
- DRUG: CellCept® (Mycophenolate mofetil) OR Rapamune® (Sirolimus)
- DRUG: Prograf® (Tacrolimus) OR Cyclosporine
- DRUG: Thymoglobulin® (Anti-thymocyte Globulin) - at first transplant
- DRUG: Simulect® (Basiliximab) - at 2nd or 3rd transplant
- DRUG: Klexane® (Enoxaparinsodium)
- DRUG: Trombyl® or Albyl-E® (Acetylsalicylicacid- ASA)
- DRUG: Enbrel® (Etanercept)
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
- [object Object]
- [object Object]